CLINICAL_TRIALS
trial_result
· 2024-06-26
Clinical Trial Update: Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial [NA]
Summary
The HABIT trial evaluating adherence to hydroxyurea in sickle cell disease has completed, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Sickle Cell Disease | NA | Status: COMPLETED | Results posted: 2024-06-26